Global leader in contact lens manufacturing selects Global 2.0 to manage its medical products approvals and submissions worldwide.
Framingham, MA, February 6, 2006 – clinivation, Inc. announced today that CooperVision, Inc. (NYSE: COO) has selected clinivation Global™ 2.0 software.
“We are delighted that CooperVision has selected Global 2.0 to help build and track their product approvals in the contact lens market,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer. “CooperVision’s management clearly sees the value in automating their approval process,” he continued.
Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.
About CooperVision, Inc.
CooperVision is one of the world’s leading and fastest-growing manufacturers of contact lenses, currently the third-largest manufacturer in the United States and worldwide. CooperVision is considered the world’s leading producer of premium-quality toric lenses for people with astigmatism. In addition, CooperVision manufactures lenses for people with spherical and presbyopic conditions and opaque lenses for patients who want to change the appearance of their eye color.
Visit CooperVision online at www.coopervision.com
